Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zivo Bioscience, Inc.ZIVO · Entity 9611 | Director | September 30, 2020 | December 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zivo Bioscience, Inc.
Report date September 30, 2020 · Filed December 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.12 · Expires 2025-09-30 | Direct | 500,000 |
Reported balance
After 2020-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-09-30 · Grant · Acquired 500,000 · Balance 500,000 F1: The warrants were issued to the reporting person as compensation for acting as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: The warrants were issued to the reporting person as compensation for acting as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2020 Filed Dec 2, 2020 00:39 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001078782-20-000936 · primary_doc.xml · derivative · entry 1 RONDEAU ROBERT O JR · CIK 0001669678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2025-09-30 F1 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 26, 2019 Filed Apr 8, 2020 19:50 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-20-000240 · primary_doc.xml · derivative · entry 4 RONDEAU ROBERT O JR · CIK 0001669678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2024-09-26 F1 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 28, 2018 Filed Apr 8, 2020 19:50 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.14 | Not disclosed |
DisclosureSEC source: 0001078782-20-000240 · primary_doc.xml · derivative · entry 3 RONDEAU ROBERT O JR · CIK 0001669678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2023-09-28 F1 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 11, 2017 Filed Apr 8, 2020 19:50 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001078782-20-000240 · primary_doc.xml · derivative · entry 2 RONDEAU ROBERT O JR · CIK 0001669678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2022-09-11 F1 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 10, 2016 Filed Apr 8, 2020 19:50 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 250,000 | Not disclosed Strike: $0.05 | Not disclosed |
DisclosureSEC source: 0001078782-20-000240 · primary_doc.xml · derivative · entry 1 RONDEAU ROBERT O JR · CIK 0001669678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2021-09-10 F1 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.